Guaifenesin
40291505-55ca-0759-e063-6394a90acee1
34390-5
HUMAN OTC DRUG LABEL
Drug Facts
Composition & Product
Identifiers & Packaging
Description
cough, cold
Medication Information
Warnings and Precautions
Indications and Usage
cough, cold
Dosage and Administration
Description
cough, cold
Section 51727-6
Calcium sennosides 20% IH, Colloidal Silicon Di oxide USP/NF, Croscarmellose sodium USP/NF, Crospovidone [Kollidon] USP/NF, Dicalcium phosphate/ dibasic calcium phosphate [DIREC] USP/NF, Filmcoat AMB-51D0393632-Blue lake IH, Magnesium stearate. USP/NF, Microcrystalline cellulose (PH-102) USP/NF, Sodium lauryl sulfate USP/NF, Stearic acid powder USP/NF, Purified water
Section 51945-4
Sennosides Tablets USP, 25 mg Label
Section 55105-1
Structured Label Content
Indications and Usage (34067-9)
cough, cold
Dosage and Administration (34068-7)
Warnings and Precautions (34071-1)
Section 51727-6 (51727-6)
Calcium sennosides 20% IH, Colloidal Silicon Di oxide USP/NF, Croscarmellose sodium USP/NF, Crospovidone [Kollidon] USP/NF, Dicalcium phosphate/ dibasic calcium phosphate [DIREC] USP/NF, Filmcoat AMB-51D0393632-Blue lake IH, Magnesium stearate. USP/NF, Microcrystalline cellulose (PH-102) USP/NF, Sodium lauryl sulfate USP/NF, Stearic acid powder USP/NF, Purified water
Section 51945-4 (51945-4)
Sennosides Tablets USP, 25 mg Label
Section 55105-1 (55105-1)
Advanced Ingredient Data
Raw Label Data
All Sections (JSON)
Additional Information
Back to search View SPL set listing Open on DailyMed ↗
Source: dailymed · Ingested: 2026-02-15T12:07:09.267658 · Updated: 2026-03-14T23:10:23.192014